D.A. Davidson & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.5M | Sell |
212,815
-6,899
| -3% | -$1.06M | 0.2% | 85 |
|
|
2025
Q4 | $30.3M | Sell |
219,714
-4,833
| -2% | -$633K | 0.19% | 88 |
|
|
2025
Q3 | $28.8M | Sell |
224,547
-106,074
| -32% | -$12.9M | 0.18% | 97 |
|
|
2025
Q2 | $40M | Sell |
330,621
-68,710
| -17% | -$7.74M | 0.28% | 66 |
|
|
2025
Q1 | $44.5M | Sell |
399,331
-65,251
| -14% | -$6.95M | 0.36% | 56 |
|
|
2024
Q4 | $45.2M | Sell |
464,582
-22,558
| -5% | -$2.41M | 0.37% | 48 |
|
|
2024
Q3 | $56M | Sell |
487,140
-4,942
| -1% | -$561K | 0.46% | 44 |
|
|
2024
Q2 | $52.4M | Sell |
492,082
-1,220
| -0.2% | -$122K | 0.46% | 43 |
|
|
2024
Q1 | $47.7M | Buy |
493,302
+6,225
| +1% | +$638K | 0.43% | 44 |
|
|
2023
Q4 | $49.2M | Sell |
487,077
-10,100
| -2% | -$975K | 0.48% | 43 |
|
|
2023
Q3 | $50.6M | Buy |
497,177
+669
| +0.1% | +$67.9K | 0.55% | 37 |
|
|
2023
Q2 | $50.1M | Sell |
496,508
-20,901
| -4% | -$2.09M | 0.53% | 37 |
|
|
2023
Q1 | $47.6M | Buy |
517,409
+29,725
| +6% | +$2.6M | 0.54% | 38 |
|
|
2022
Q4 | $44.2M | Buy |
487,684
+3,819
| +0.8% | +$322K | 0.52% | 42 |
|
|
2022
Q3 | $36.8M | Buy |
483,865
+10,043
| +2% | +$832K | 0.48% | 46 |
|
|
2022
Q2 | $40.1M | Buy |
473,822
+4,237
| +0.9% | +$372K | 0.5% | 39 |
|
|
2022
Q1 | $41.2M | Buy |
469,585
+20,123
| +4% | +$1.74M | 0.45% | 47 |
|
|
2021
Q4 | $39.3M | Buy |
449,462
+15,638
| +4% | +$1.3M | 0.42% | 52 |
|
|
2021
Q3 | $35.5M | Buy |
433,824
+3,455
| +0.8% | +$311K | 0.41% | 47 |
|
|
2021
Q2 | $39.3M | Buy |
430,369
+17,893
| +4% | +$1.59M | 0.46% | 44 |
|
|
2021
Q1 | $35.3M | Buy |
412,476
+60,072
| +17% | +$5.39M | 0.45% | 45 |
|
|
2020
Q4 | $33.3M | Buy |
352,404
+12,657
| +4% | +$1.11M | 0.51% | 39 |
|
|
2020
Q3 | $29.5M | Buy |
339,747
+12,656
| +4% | +$1.1M | 0.51% | 40 |
|
|
2020
Q2 | $28.6M | Sell |
327,091
-54,306
| -14% | -$4.69M | 0.53% | 38 |
|
|
2020
Q1 | $31.4M | Buy |
381,397
+25,513
| +7% | +$2.28M | 0.61% | 35 |
|
|
2019
Q4 | $33.7M | Buy |
355,884
+16,123
| +5% | +$1.45M | 0.54% | 41 |
|
|
2019
Q3 | $29.5M | Buy |
339,761
+10,687
| +3% | +$960K | 0.53% | 42 |
|
|
2019
Q2 | $30M | Sell |
329,074
-208,665
| -39% | -$17.7M | 0.56% | 40 |
|
|
2019
Q1 | $46.2M | Buy |
537,739
+9,657
| +2% | +$775K | 0.79% | 29 |
|
|
2018
Q4 | $40.6M | Buy |
528,082
+13,020
| +3% | +$1.01M | 0.79% | 30 |
|
|
2018
Q3 | $39.8M | Buy |
515,062
+23,966
| +5% | +$1.77M | 0.71% | 30 |
|
|
2018
Q2 | $33.2M | Buy |
491,096
+11,087
| +2% | +$765K | 0.65% | 31 |
|
|
2018
Q1 | $34.8M | Buy |
480,009
+7,325
| +2% | +$558K | 0.72% | 28 |
|
|
2017
Q4 | $35.6M | Sell |
472,684
-103,316
| -18% | -$7.8M | 0.75% | 30 |
|
|
2017
Q3 | $44.3M | Buy |
576,000
+3,769
| +0.7% | +$285K | 0.87% | 16 |
|
|
2017
Q2 | $42.8M | Buy |
572,231
+61,460
| +12% | +$4.36M | 0.97% | 18 |
|
|
2017
Q1 | $34M | Buy |
510,771
+55,374
| +12% | +$3.69M | 0.82% | 22 |
|
|
2016
Q4 | $29.7M | Buy |
455,397
+27,516
| +6% | +$1.78M | 0.67% | 27 |
|
|
2016
Q3 | $30.3M | Buy |
427,881
+47,238
| +12% | +$3.44M | 0.75% | 22 |
|
|
2016
Q2 | $28.1M | Buy |
380,643
+38,589
| +11% | +$2.67M | 0.83% | 18 |
|
|
2016
Q1 | $22.2M | Buy |
342,054
+20,682
| +6% | +$1.41M | 0.69% | 22 |
|
|
2015
Q4 | $24.8M | Buy |
321,372
+17,505
| +6% | +$1.39M | 0.81% | 21 |
|
|
2015
Q3 | $25M | Buy |
303,867
+3,700
| +1% | +$329K | 0.88% | 17 |
|
|
2015
Q2 | $26.4M | Buy |
300,167
+1,423
| +0.5% | +$131K | 0.87% | 15 |
|
|
2015
Q1 | $26.4M | Sell |
298,744
-9,269
| -3% | -$822K | 0.87% | 17 |
|
|
2014
Q4 | $25.6M | Buy |
308,013
+2,757
| +0.9% | +$229K | 0.84% | 19 |
|
|
2014
Q3 | $25.7M | Buy |
305,256
+9,516
| +3% | +$770K | 0.87% | 16 |
|
|
2014
Q2 | $24M | Buy |
295,740
+26,037
| +10% | +$2.05M | 0.81% | 19 |
|
|
2014
Q1 | $20.5M | Buy |
269,703
+20,679
| +8% | +$1.51M | 0.73% | 23 |
|
|
2013
Q4 | $17.9M | Buy |
249,024
+9,979
| +4% | +$694K | 0.67% | 27 |
|
|
2013
Q3 | $16.4M | Buy |
239,045
+15,941
| +7% | +$1.05M | 0.74% | 21 |
|
|
2013
Q2 | $14.1M | Buy |
+223,104
| New | +$14.5M | 0.68% | 24 |
|
Other funds holding NVS
D.A. Davidson & Co's NVS Position: Q1 2026 in Review
D.A. Davidson & Co reduced its Novartis (NVS) stake by 3.1% in Q1 2026, selling an estimated $1.06M and leaving 212,815 shares worth $32.5M. The position accounts for 0.2% of the portfolio, ranked #85.
D.A. Davidson & Co first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $56M in Q3 2024. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- D.A. Davidson & Co held 212,815 shares of Novartis worth $32.5M as of Q1 2026.
- D.A. Davidson & Co sold 6,899 Novartis shares in Q1 2026, an estimated $1.06M.
- Novartis made up 0.2% of D.A. Davidson & Co's portfolio in Q1 2026, its #85 holding.
- D.A. Davidson & Co first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- D.A. Davidson & Co's Novartis position peaked at $56M in Q3 2024.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.